Full-Time

Senior Director

Oncology Strategic Pricing and Contracting

Posted on 4/18/2024

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulation technologies for diseases

Biotechnology

Compensation Overview

$252,000 - $300,000Annually

Senior

Menlo Park, CA, USA

Required Skills
Communications
Data Analysis
Requirements
  • Experience leading pricing and contracting teams in oncology
  • Experience with oral oncology therapies and contracting with community oncology practices with dispensing capabilities
  • Experience launching oral oncology therapies in the community oncology setting
  • Demonstrated ability to manage, lead, and coach teams to meet objectives and drive results within agreed upon timelines
  • Effective oral and written communication skills and ability to engage all levels of the organization including the C-Suite level
  • Excellent negotiation skills with a focus on finding solutions to meet organizational goals
  • Collaborative style fostering cross-functional collaboration
  • Working knowledge of US healthcare policies and relevant legal, compliance, regulatory, and reporting requirements
  • Ability to work onsite at Corcept headquarters in Menlo Park and travel approximately 20% of the time
Responsibilities
  • Strategic Pricing and Contracting
  • Pricing and Contracting Governance
  • Pricing and Contract/Deal Analytics
  • Payer Contract Negotiations
  • Documentation and Record Keeping
  • Contract Operations
  • Government Contracting and Price Reporting
  • Gross to Net
  • Collaborate to Develop and Update Brand Forecasts
  • Monitor Reimbursement and Legislative Policy Environment and Address Opportunities and Challenges

Corcept Therapeutics specializes in developing selective glucocorticoid receptor antagonists to address the adverse effects of excess cortisol in a range of diseases, with a primary emphasis on creating a new generation of compounds aimed at mitigating the effects of excess cortisol in various diseases. Their focus is on cortisol modulation technologies for endocrine, metabolic, oncologic, and psychiatric disorders, with a pipeline of over 30 ongoing studies.

Company Stage

IPO

Total Funding

$119.1M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

8%

1 year growth

15%

2 year growth

38%
INACTIVE